Commonwealth Financial Services’s GSK GSK Stock Holding History

Commonwealth Financial Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$230K	Buy	4,398 +9	+0.2%	+$457	0.25%	48
2016 Q4	$212K	Sell	4,389 -791	-15%	-$39.1K	0.21%	50
2016 Q3	$279K	Buy	5,180 +1,961	+61%	+$108K	0.26%	47
2016 Q2	$174K	Sell	3,219 -335	-9%	-$17.6K	0.2%	53
2016 Q1	$180K	Sell	3,554 -1,471	-29%	-$73.3K	0.27%	39
2015 Q4	$253K	Sell	5,025 -653	-12%	-$33.3K	0.86%	38
2015 Q3	$273K	Hold	5,678	–	–	0.32%	37
2015 Q2	$296K	Sell	5,678 -61	-1%	-$3.44K	0.32%	40
2015 Q1	$331K	Buy	5,739 +217	+4%	+$12.4K	0.29%	44
2014 Q4	$295K	Buy	+5,522	New	+$309K	0.26%	44

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Commonwealth Financial Services's GSK Position: Q1 2017 in Review

Commonwealth Financial Services increased its GSK (GSK) stake by 0.21% in Q1 2017, buying an estimated $457 and bringing the position to 4,398 shares worth $230K. The position accounts for 0.25% of the portfolio, ranked #48.

Commonwealth Financial Services first reported a position in GSK in Q4 2014 and has held it in 10 quarters since. The position peaked at $331K in Q1 2015. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Commonwealth Financial Services held 4,398 shares of GSK worth $230K as of Q1 2017.
Commonwealth Financial Services bought 9 GSK shares in Q1 2017, an estimated $457.
GSK made up 0.25% of Commonwealth Financial Services's portfolio in Q1 2017, its #48 holding.
Commonwealth Financial Services first reported a position in GSK in Q4 2014 and has held it in 10 quarters since.
Commonwealth Financial Services's GSK position peaked at $331K in Q1 2015.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Commonwealth Financial Services's 13F filing for Q1 2017, filed 20 Apr 2017.